Ordering Recommendations

The 4 in 1 test is intended for the primary diagnosis of Influenza A, Influenza B, RSV or COVID-19. This 4 in 1 combo test is to be used when Influenza infection status will alter treatment decisions, such as when the patient is eligible for Influenza retroviral therapy.

EPIC Test Code

LAB7110

Methodology

Nucleic acid amplification (NAA) by RT-PCR and/or TMA.

Performed

Daily

Reported

Within 24 hrs, STAT requests are not available

Collect

Nasopharyngeal swabs (flexible rayon-tipped applicators) are the only acceptable specimens for testing.
Collect specimen by insertion of NP swab into one nostril and back to the nasopharynx.  
Swab back and forth, or rotate the swab over the mucosa surface.
Place swab in Viral Transport Media (UTM).

Storage/Transport Temperature

Refrigerated

Place Nasopharyngeal Swabs (Flexible Rayon-Tipped Applicators) into Universal Transport Medium (UTM/VTM/M4).

Standard Volume

One nasopharyngeal swab in 2-3 mL viral transport media

Unacceptable Conditions


Specimens received outside of stated stability limits.
Dry swabs not in listed transport media.
Alternate specimen sources and transport media have not been validated with this assay and will not be tested.

Stability (from collection to initiation)

Testing Lab - Methodology Room Temperature Refrigerated Frozen
Salem Health, State Street Lab - Panther Fusion 12 hours 4 days 3 months
Salem Health Hospital Lab - GeneXpert 2 days 7 days 12 months (1 freeze/thaw cycle)

Tests included in Panel

Influenza A
Influenza B
RSV
COVID-19

CPT Codes

87631, 87635

Collect

Nasopharyngeal swabs (flexible rayon-tipped applicators) are the only acceptable specimens for testing.
Collect specimen by insertion of NP swab into one nostril and back to the nasopharynx.  
Swab back and forth, or rotate the swab over the mucosa surface.
Place swab in Viral Transport Media (UTM).

Standard Volume

One nasopharyngeal swab in 2-3 mL viral transport media

Unacceptable Conditions


Specimens received outside of stated stability limits.
Dry swabs not in listed transport media.
Alternate specimen sources and transport media have not been validated with this assay and will not be tested.

Stability (from collection to initiation)

Testing Lab - Methodology Room Temperature Refrigerated Frozen
Salem Health, State Street Lab - Panther Fusion 12 hours 4 days 3 months
Salem Health Hospital Lab - GeneXpert 2 days 7 days 12 months (1 freeze/thaw cycle)

Synonyms

  • LAB7110
  • Influenza A
  • Influenza B
  • Flu
  • RSV
  • COVID-19
  • COVID
  • Coronavirus

Performed

Daily

Reported

Within 24 hrs, STAT requests are not available

Collect

Nasopharyngeal swabs (flexible rayon-tipped applicators) are the only acceptable specimens for testing.
Collect specimen by insertion of NP swab into one nostril and back to the nasopharynx.  
Swab back and forth, or rotate the swab over the mucosa surface.
Place swab in Viral Transport Media (UTM).

Standard Volume

One nasopharyngeal swab in 2-3 mL viral transport media

Unacceptable Conditions


Specimens received outside of stated stability limits.
Dry swabs not in listed transport media.
Alternate specimen sources and transport media have not been validated with this assay and will not be tested.

Stability (from collection to initiation)

Testing Lab - Methodology Room Temperature Refrigerated Frozen
Salem Health, State Street Lab - Panther Fusion 12 hours 4 days 3 months
Salem Health Hospital Lab - GeneXpert 2 days 7 days 12 months (1 freeze/thaw cycle)

Tests included in Panel

Influenza A
Influenza B
RSV
COVID-19

Lab Location

State Street Laboratory

Department

Molecular

Synonyms

  • LAB7110
  • Influenza A
  • Influenza B
  • Flu
  • RSV
  • COVID-19
  • COVID
  • Coronavirus

Ordering Recommendations

The 4 in 1 test is intended for the primary diagnosis of Influenza A, Influenza B, RSV or COVID-19. This 4 in 1 combo test is to be used when Influenza infection status will alter treatment decisions, such as when the patient is eligible for Influenza retroviral therapy.

Methodology

Nucleic acid amplification (NAA) by RT-PCR and/or TMA.

Performed

Daily

Reported

Within 24 hrs, STAT requests are not available

Unacceptable Conditions


Specimens received outside of stated stability limits.
Dry swabs not in listed transport media.
Alternate specimen sources and transport media have not been validated with this assay and will not be tested.

Reference Interval

Influenza A: Negative
Influenza B: Negative
Respiratory Syncytial Virus (RSV): Negative
SARS-CoV-2 (COVID-19): Negative

Interpretive Data

Target Result Interpretation
Influenza A Positive Influenza A RNA Detected
Influenza A Negative No Influenza A RNA Detected
Influenza A Invalid Presence or absence of the target RNA could not be determined after repeat testing. Specimen or Processing controls did not meet acceptance criteria. Suggest recollection if clinically indicated.
Influenza B Positive Influenza B RNA Detected
Influenza B Negative No Influenza B RNA Detected
Influenza B Invalid Presence or absence of the target RNA could not be determined after repeat testing. Specimen or Processing controls did not meet acceptance criteria. Suggest recollection if clinically indicated.
Respiratory Syncytial Virus (RSV) Positive Respiratory Syncytial Virus RNA Detected
Respiratory Syncytial Virus (RSV) Negative No Respiratory Syncytial Virus RNA Detected
Respiratory Syncytial Virus (RSV) Invalid Presence or absence of the target RNA could not be determined after repeat testing. Specimen or Processing controls did not meet acceptance criteria. Suggest recollection if clinically indicated.
SARS-CoV-2 (COVID-19) Positive SARS-CoV-2 RNA Detected
SARS-CoV-2 (COVID-19) Negative No SARS-CoV-2 RNA Detected
SARS-CoV-2 (COVID-19) Invalid Presence or absence of the target RNA could not be determined after repeat testing. Specimen or Processing controls did not meet acceptance criteria. Suggest recollection if clinically indicated.

EPIC Test Code

LAB7110

CPT Codes

87631, 87635
Overview

Ordering Recommendations

The 4 in 1 test is intended for the primary diagnosis of Influenza A, Influenza B, RSV or COVID-19. This 4 in 1 combo test is to be used when Influenza infection status will alter treatment decisions, such as when the patient is eligible for Influenza retroviral therapy.

EPIC Test Code

LAB7110

Methodology

Nucleic acid amplification (NAA) by RT-PCR and/or TMA.

Performed

Daily

Reported

Within 24 hrs, STAT requests are not available

Collect

Nasopharyngeal swabs (flexible rayon-tipped applicators) are the only acceptable specimens for testing.
Collect specimen by insertion of NP swab into one nostril and back to the nasopharynx.  
Swab back and forth, or rotate the swab over the mucosa surface.
Place swab in Viral Transport Media (UTM).

Storage/Transport Temperature

Refrigerated

Place Nasopharyngeal Swabs (Flexible Rayon-Tipped Applicators) into Universal Transport Medium (UTM/VTM/M4).

Standard Volume

One nasopharyngeal swab in 2-3 mL viral transport media

Unacceptable Conditions


Specimens received outside of stated stability limits.
Dry swabs not in listed transport media.
Alternate specimen sources and transport media have not been validated with this assay and will not be tested.

Stability (from collection to initiation)

Testing Lab - Methodology Room Temperature Refrigerated Frozen
Salem Health, State Street Lab - Panther Fusion 12 hours 4 days 3 months
Salem Health Hospital Lab - GeneXpert 2 days 7 days 12 months (1 freeze/thaw cycle)

Tests included in Panel

Influenza A
Influenza B
RSV
COVID-19

CPT Codes

87631, 87635
Collection Information

Collect

Nasopharyngeal swabs (flexible rayon-tipped applicators) are the only acceptable specimens for testing.
Collect specimen by insertion of NP swab into one nostril and back to the nasopharynx.  
Swab back and forth, or rotate the swab over the mucosa surface.
Place swab in Viral Transport Media (UTM).

Standard Volume

One nasopharyngeal swab in 2-3 mL viral transport media

Unacceptable Conditions


Specimens received outside of stated stability limits.
Dry swabs not in listed transport media.
Alternate specimen sources and transport media have not been validated with this assay and will not be tested.

Stability (from collection to initiation)

Testing Lab - Methodology Room Temperature Refrigerated Frozen
Salem Health, State Street Lab - Panther Fusion 12 hours 4 days 3 months
Salem Health Hospital Lab - GeneXpert 2 days 7 days 12 months (1 freeze/thaw cycle)

Synonyms

  • LAB7110
  • Influenza A
  • Influenza B
  • Flu
  • RSV
  • COVID-19
  • COVID
  • Coronavirus
Specimen Handling

Performed

Daily

Reported

Within 24 hrs, STAT requests are not available

Collect

Nasopharyngeal swabs (flexible rayon-tipped applicators) are the only acceptable specimens for testing.
Collect specimen by insertion of NP swab into one nostril and back to the nasopharynx.  
Swab back and forth, or rotate the swab over the mucosa surface.
Place swab in Viral Transport Media (UTM).

Standard Volume

One nasopharyngeal swab in 2-3 mL viral transport media

Unacceptable Conditions


Specimens received outside of stated stability limits.
Dry swabs not in listed transport media.
Alternate specimen sources and transport media have not been validated with this assay and will not be tested.

Stability (from collection to initiation)

Testing Lab - Methodology Room Temperature Refrigerated Frozen
Salem Health, State Street Lab - Panther Fusion 12 hours 4 days 3 months
Salem Health Hospital Lab - GeneXpert 2 days 7 days 12 months (1 freeze/thaw cycle)

Tests included in Panel

Influenza A
Influenza B
RSV
COVID-19

Lab Location

State Street Laboratory

Department

Molecular

Synonyms

  • LAB7110
  • Influenza A
  • Influenza B
  • Flu
  • RSV
  • COVID-19
  • COVID
  • Coronavirus
Result Interpretation

Ordering Recommendations

The 4 in 1 test is intended for the primary diagnosis of Influenza A, Influenza B, RSV or COVID-19. This 4 in 1 combo test is to be used when Influenza infection status will alter treatment decisions, such as when the patient is eligible for Influenza retroviral therapy.

Methodology

Nucleic acid amplification (NAA) by RT-PCR and/or TMA.

Performed

Daily

Reported

Within 24 hrs, STAT requests are not available

Unacceptable Conditions


Specimens received outside of stated stability limits.
Dry swabs not in listed transport media.
Alternate specimen sources and transport media have not been validated with this assay and will not be tested.

Reference Interval

Influenza A: Negative
Influenza B: Negative
Respiratory Syncytial Virus (RSV): Negative
SARS-CoV-2 (COVID-19): Negative

Interpretive Data

Target Result Interpretation
Influenza A Positive Influenza A RNA Detected
Influenza A Negative No Influenza A RNA Detected
Influenza A Invalid Presence or absence of the target RNA could not be determined after repeat testing. Specimen or Processing controls did not meet acceptance criteria. Suggest recollection if clinically indicated.
Influenza B Positive Influenza B RNA Detected
Influenza B Negative No Influenza B RNA Detected
Influenza B Invalid Presence or absence of the target RNA could not be determined after repeat testing. Specimen or Processing controls did not meet acceptance criteria. Suggest recollection if clinically indicated.
Respiratory Syncytial Virus (RSV) Positive Respiratory Syncytial Virus RNA Detected
Respiratory Syncytial Virus (RSV) Negative No Respiratory Syncytial Virus RNA Detected
Respiratory Syncytial Virus (RSV) Invalid Presence or absence of the target RNA could not be determined after repeat testing. Specimen or Processing controls did not meet acceptance criteria. Suggest recollection if clinically indicated.
SARS-CoV-2 (COVID-19) Positive SARS-CoV-2 RNA Detected
SARS-CoV-2 (COVID-19) Negative No SARS-CoV-2 RNA Detected
SARS-CoV-2 (COVID-19) Invalid Presence or absence of the target RNA could not be determined after repeat testing. Specimen or Processing controls did not meet acceptance criteria. Suggest recollection if clinically indicated.
Administrative

EPIC Test Code

LAB7110

CPT Codes

87631, 87635

×
Learn More Remind Me Later Dismiss